A new strategy puts asthma guidelines to the test — could it cut flare-ups in half?
NCT ID NCT07718724
First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time
Summary
This trial tests whether a structured care pathway — based on standard asthma guidelines — can improve disease management for adults with uncontrolled asthma who already use high-dose inhalers. Doctors and nurses at some clinics will receive extra training and tools to follow the guidelines closely, while others continue usual care. The study will compare rates of severe asthma diagnoses and flare-ups over nearly a year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a guideline-directed medical therapy (GDMT) pathway for physicians and nurses
- What this could lead to
- If successful, this approach could improve asthma control and reduce severe flare-ups for people whose asthma is not well managed by standard inhalers.
- What could go wrong
- This is a behavioral intervention, not a new drug, so its impact may be modest. Results depend on how consistently doctors and nurses follow the pathway.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNCONTROLLED ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Northan Jiangsu People's Hospital
Yangzhou, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.